Home › Squamous Cell Carcinoma › Illinois › Chicago
Squamous Cell Carcinoma clinical trials in Chicago, IL
5 studies for Squamous Cell Carcinoma are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecruitingPhase 1/2
- University of Illinois Cancer Center, Chicago
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
RecruitingPhase 2/3
- University of Illinois Cancer Center, Chicago
Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment
RecruitingPhase 2
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
RecruitingPhase 3
- University of Illinois Cancer Center, Chicago
Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
RecruitingPhase 1
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Squamous Cell Carcinoma trials in other cities
- Pittsburgh, PA11 studies
- Los Angeles, CA9 studies
- Nashville, TN8 studies
- New York City, NY7 studies
- Boston, MA7 studies
- Houston, TX7 studies
- Durham, NC6 studies
- St. Louis, MO6 studies
- San Diego, CA6 studies
- Queens, NY4 studies
- Washington, DC4 studies
- Orlando, FL4 studies
Other studies in Chicago
- Breast Cancer59 studies
- Non-Small Cell Lung Cancer59 studies
- Cancer (all types)51 studies
- Prostate Cancer45 studies
- Lung Cancer43 studies
- Metastatic Cancer42 studies
- Obesity40 studies
- Ovarian Cancer36 studies
- Colorectal Cancer32 studies
- Stroke31 studies
- Head and Neck Squamous Cell Carcinoma29 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.